arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Progyny, Inc.

PGNY
$28.11 ▼ -2.09 (-6.90%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
9 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
69
Health
Good
Neutral
auto_awesome

Analytical Summary

Progyny, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $2.4B
Dividend Yield
Revenue Growth 10.4%
Op. Margin 6.6%
ROIC 10.1%
FCF / Share $2.24
Trailing P/E 41.3x
Price / Book 4.5x
FCF Yield 8.0%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.29B
↑ +10.4%
Net Income Profit after all expenses
$58.52M
↑ +7.7%
Operating Margin Operating profit as % of sales
6.6%
↑ +14.5% 47th
FCF / Share Free cash flow per share
$2.24
↑ +17.9%

Health Breakdown

Profitability
56
Returns
72
Cash Quality
92

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters